Assignee
SUMITOMO PHARMA CO LTD
JP·61 granted patents·64 pending applications·42 citations·filing 1987–2025
Top patents by PatentIndex Score
125 records- 0191US11911466B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·27 claims
- 0291US11401261B22-heteroaryl aminoquinazolinone derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Aug 2, 2022·2 cites·18 claims
- 0390US11564920B25-heteroaryl-1H-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jan 31, 2023·2 cites·18 claims
- 0489US11911381B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Feb 27, 2024·1 cites·15 claims
- 0588US11759509B2WT1 antigen peptide conjugate vaccineSUMITOMO PHARMA CO LTD·Filed 2018·Granted Sep 19, 2023·2 cites·13 claims
- 0687US12440560B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO PHARMA CO LTD·Filed 2024·Granted Oct 14, 2025·0 cites·7 claims
- 0787US11371016B2Method for producing retinal tissueSUMITOMO PHARMA CO LTD·Filed 2017·Granted Jun 28, 2022·4 cites·22 claims
- 0887US2026053911A1Pyrimidine compoundSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0987US2025332166A1Treatment of prostate cancerSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1086US12077546B2Bicyclic pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Sep 3, 2024·2 cites·25 claims
- 1186US11718592B2Oxadiazole derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Aug 8, 2023·1 cites·30 claims
- 1284US11628169B2Therapeutic drug for motor complications in Parkinson's diseaseSUMITOMO PHARMA CO LTD·Filed 2021·Granted Apr 18, 2023·1 cites·24 claims
- 1383US11833247B2Vaccine adjuvant formulationSUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 5, 2023·1 cites·18 claims
- 1483US11795195B2Antibody-drug conjugates including hemiasterlin derivativeSUMITOMO PHARMA CO LTD·Filed 2018·Granted Oct 24, 2023·2 cites·24 claims
- 1583US2026078115A1Aliphatic acid amide derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 1681US12263167B2Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Granted Apr 1, 2025·0 cites·19 claims
- 1780US12221625B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2023·Granted Feb 11, 2025·0 cites·24 claims
- 1880US12172987B2Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·30 claims
- 1979US12077510B2Carboxylic acid compoundsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Sep 3, 2024·0 cites·4 claims
- 2079US11618883B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2018·Granted Apr 4, 2023·1 cites·17 claims
- 2178US11731960B2Biheterocyclic compoundSUMITOMO PHARMA CO LTD·Filed 2022·Granted Aug 22, 2023·0 cites·17 claims
- 2278US11649432B2Method for producing retinal pigment epithelial cellsSUMITOMO PHARMA CO LTD·Filed 2016·Granted May 16, 2023·1 cites·24 claims
- 2378US2025382282A1Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 2478US2025084090A1Substituted lactams showing serotonin 5-ht receptor activitySUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 2577US2023399308A12,6-disubstituted pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 2676US12398125B2Nitrogen-containing saturated heterocyclyl derivativeSUMITOMO PHARMA CO LTD·Filed 2023·Granted Aug 26, 2025·0 cites·43 claims
- 2776US11925621B2Medicinal preparation for external useSUMITOMO PHARMA CO LTD·Filed 2019·Granted Mar 12, 2024·1 cites·13 claims
- 2876US11466007B2Substituted lactams showing serotonin 5-HT receptor activitySUMITOMO PHARMA CO LTD·Filed 2019·Granted Oct 11, 2022·1 cites·31 claims
- 2975US12398149B2Dihydrochromene derivativesSUMITOMO PHARMA CO LTD·Filed 2023·Granted Aug 26, 2025·0 cites·9 claims
- 3075US2026042775A1Crystalline forms of n-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-n'-methoxyureaSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3174US12150941B2Process for preparing substituted pyrazolo[1,5-a]pyrazinesSUMITOMO PHARMA CO LTD·Filed 2023·Granted Nov 26, 2024·0 cites·6 claims
- 3272US12291720B2Production method for retinal tissueSUMITOMO PHARMA CO LTD·Filed 2022·Granted May 6, 2025·0 cites·18 claims
- 3372US12180213B2Substituted pyrazoles showing serotonin 5-HT receptor activitySUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 31, 2024·0 cites·31 claims
- 3472US2025177395A1Optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3572US2024059732A1Antibody-Drug Conjugates Including Hemiasterlin DerivativeSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 3671US12020824B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2022·Granted Jun 25, 2024·0 cites·12 claims
- 3771US11535599B2Benzisoxazole derivativeSUMITOMO PHARMA CO LTD·Filed 2022·Granted Dec 27, 2022·0 cites·28 claims
- 3871US2024355433A1Clinical trial site selection and interactive visualizationSUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 3970US12000844B2Diagnostic drug and diagnostic method for Alzheimer's diseaseSUMITOMO PHARMA CO LTD·Filed 2019·Granted Jun 4, 2024·1 cites·17 claims
- 4070US11780820B22,6-disubstituted pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2021·Granted Oct 10, 2023·0 cites·40 claims
- 4170US11495358B2Virtual reality video reproduction apparatus, and method of using the sameSUMITOMO PHARMA CO LTD·Filed 2021·Granted Nov 8, 2022·0 cites·14 claims
- 4270US11440905B2Biheterocyclic compoundSUMITOMO PHARMA CO LTD·Filed 2020·Granted Sep 13, 2022·0 cites·21 claims
- 4370US2023240994A1Medicament-containing hollow particleSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 4470US2026035379A1Bicyclic pyridine derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 4570US2026022109A15-heteroaryl-1h-pyrazol-3-amine derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 4669US11661397B21,4-disubstituted imidazole derivativeSUMITOMO PHARMA CO LTD·Filed 2020·Granted May 30, 2023·0 cites·7 claims
- 4769US2026027114A1Medicament for treating cancer comprising optically active azabicyclo ring derivativeSUMITOMO PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 4869US2024293521A1Combination use of wt1 antigen peptide and immunomodulatorSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 4968US2023287009A1Oxo-substituted compoundSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
- 5067US2023298707A1Systems and methods for clinical trial results endpoint-based analysis and dynamic aggregationSUMITOMO PHARMA CO LTD·Filed 2023·Application pending·0 cites
Showing the top 50 of 125 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →